You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 2, February 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  VIGNETTES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Parathyroid Hormone-Related Protein in Patients With Malignant Melanoma

A. N. Elias, MD; M. R. Pandian, PhD; J. Jacowatz, MD
Department of Medicine; Department of Surgery University of California Irvine, CA 92717

Arch Dermatol. 1992;128(2):278-279.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Parathyroid hormone—related protein (PTHrP) is a hormone that was initially isolated from the tumors of patients with the syndrome of humoral hypercalcemia of malignancy. Since most patients with the syndrome from whom PTHrP was isolated had squamous cell cancers, attempts were made to try to isolate PTHrP from the skin of normal individuals.1 This was subsequently accomplished, and PTHrP was found to be present in the keratinoctyes of normal skin.2 Although PTHrP is produced in abundant amounts by keratinocytes in cell culture, the biologically active peptide has not been isolated from normal skin.1 Its presence in normal skin was inferred from the identification of PTHrP-specific messenger RNA in the epidermis3 and by immunohistochemical localization.4 Until recently, it was not clear whether PTHrP was produced only in keratinocytes or in other areas of the skin. Using affinity-purified polyclonal antiserum against synthetic try-36-PTHrP(1-36)amide, PTHrP . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.